{"protocolSection":{"identificationModule":{"nctId":"NCT00830843","orgStudyIdInfo":{"id":"1-citerio"},"organization":{"fullName":"Azienda Ospedaliera San Gerardo di Monza","class":"OTHER"},"briefTitle":"Inhalatorial Sedation in Patient With Subarachnoid Hemorrhage (SAH) Versus Conventional Intravenous Sedation","officialTitle":"Inhalatorial Sedation in Patient With SAH Versus Conventional Intravenous Sedation (GAS-SAH)","acronym":"GAS-SAH"},"statusModule":{"statusVerifiedDate":"2011-11","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2009-01"},"primaryCompletionDateStruct":{"date":"2011-07","type":"ACTUAL"},"completionDateStruct":{"date":"2011-07","type":"ACTUAL"},"studyFirstSubmitDate":"2009-01-27","studyFirstSubmitQcDate":"2009-01-27","studyFirstPostDateStruct":{"date":"2009-01-28","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-08-19","lastUpdatePostDateStruct":{"date":"2016-08-22","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Prof. Giuseppe Citerio","investigatorTitle":"MD","investigatorAffiliation":"Azienda Ospedaliera San Gerardo di Monza"},"leadSponsor":{"name":"Azienda Ospedaliera San Gerardo di Monza","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"Recent study has shown that inhalatory sedation is a practicable, effective and not risky method in Intensive Care Unit. Sevoflurane effect on cerebral system have been described in previous studies: it causes an increasing of cerebral blood flow and a decrease of oxygen cerebral consumption. Clinical strategy for Subarachnoid Hemorrhage is orientated to increase cerebral blood flow to limit vasospasm phenomena after SAH. Scope of this study is to evaluate the Cerebral Blood Flow variation associated to Isoflurane sedation versus conventional sedation with propofol ."},"conditionsModule":{"conditions":["Stroke","Subarachnoid Hemorrhage"],"keywords":["SAH","sedation","anesthesia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":13,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Propofol","type":"ACTIVE_COMPARATOR","description":"Propofol(3-4 mg/kg/ora)administrated for 2 hours.","interventionNames":["Drug: Propofol"]},{"label":"Isoflurane","type":"EXPERIMENTAL","description":"Isoflurane inhalatorial administration for 2 hours at 0.8-1.0% Minimum Alveolar Concentration","interventionNames":["Drug: Isoflurane"]}],"interventions":[{"type":"DRUG","name":"Propofol","description":"Propofol(3-4 mg/kg/ora)administrated for 2 hours.","armGroupLabels":["Propofol"],"otherNames":["Diprivan"]},{"type":"DRUG","name":"Isoflurane","description":"Isoflurane inhalatorial administration for 2 hours at 0.8-1.0% Minimum Alveolar Concentration","armGroupLabels":["Isoflurane"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Cerebral Blood Flow","timeFrame":"after 2 hours of drug administration"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* diagnosis of aSAH\n* indication to DVE positioning\n* clinical indication to sedation and assisted ventilation\n* indication to ICP and CBF monitoring\n* age \\> 18\n\nExclusion Criteria:\n\n* documented cranial hypertension (ICP\\>18) not controller by liquor drainage\n* age \\< 18.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Federico Villa, MD","affiliation":"Azienda Ospedaliera San Gerardo Monza","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Azienda Ospedaliera San Gerardo","city":"Monza","country":"Italy","geoPoint":{"lat":45.58005,"lon":9.27246}}]},"referencesModule":{"references":[{"pmid":"6859608","type":"BACKGROUND","citation":"Newberg LA, Milde JH, Michenfelder JD. The cerebral metabolic effects of isoflurane at and above concentrations that suppress cortical electrical activity. Anesthesiology. 1983 Jul;59(1):23-8. doi: 10.1097/00000542-198307000-00005."},{"pmid":"3740503","type":"BACKGROUND","citation":"Maekawa T, Tommasino C, Shapiro HM, Keifer-Goodman J, Kohlenberger RW. Local cerebral blood flow and glucose utilization during isoflurane anesthesia in the rat. Anesthesiology. 1986 Aug;65(2):144-51. doi: 10.1097/00000542-198608000-00003."},{"pmid":"7856894","type":"BACKGROUND","citation":"Reinstrup P, Ryding E, Algotsson L, Messeter K, Asgeirsson B, Uski T. Distribution of cerebral blood flow during anesthesia with isoflurane or halothane in humans. Anesthesiology. 1995 Feb;82(2):359-66. doi: 10.1097/00000542-199502000-00006."},{"pmid":"18043065","type":"BACKGROUND","citation":"Zhao P, Peng L, Li L, Xu X, Zuo Z. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology. 2007 Dec;107(6):963-70. doi: 10.1097/01.anes.0000291447.21046.4d."},{"pmid":"15329594","type":"BACKGROUND","citation":"Zhao P, Zuo Z. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology. 2004 Sep;101(3):695-703. doi: 10.1097/00000542-200409000-00018."},{"pmid":"17456654","type":"BACKGROUND","citation":"McAuliffe JJ, Joseph B, Vorhees CV. Isoflurane-delayed preconditioning reduces immediate mortality and improves striatal function in adult mice after neonatal hypoxia-ischemia. Anesth Analg. 2007 May;104(5):1066-77, tables of contents. doi: 10.1213/01.ane.0000260321.62377.74."},{"pmid":"15102945","type":"BACKGROUND","citation":"Zheng S, Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol. 2004 May;65(5):1172-80. doi: 10.1124/mol.65.5.1172."},{"pmid":"18497606","type":"BACKGROUND","citation":"Lee JJ, Li L, Jung HH, Zuo Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology. 2008 Jun;108(6):1055-62. doi: 10.1097/ALN.0b013e3181730257."},{"pmid":"12105371","type":"BACKGROUND","citation":"Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke. 2002 Jul;33(7):1889-98. doi: 10.1161/01.str.0000020092.41820.58."},{"pmid":"18811990","type":"BACKGROUND","citation":"L'her E, Dy L, Pili R, Prat G, Tonnelier JM, Lefevre M, Renault A, Boles JM. Feasibility and potential cost/benefit of routine isoflurane sedation using an anesthetic-conserving device: a prospective observational study. Respir Care. 2008 Oct;53(10):1295-303."},{"pmid":"17179257","type":"BACKGROUND","citation":"Berton J, Sargentini C, Nguyen JL, Belii A, Beydon L. AnaConDa reflection filter: bench and patient evaluation of safety and volatile anesthetic conservation. Anesth Analg. 2007 Jan;104(1):130-4. doi: 10.1213/01.ane.0000248221.44383.43."},{"pmid":"15753751","type":"BACKGROUND","citation":"Sackey PV, Martling CR, Nise G, Radell PJ. Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the Anesthetic Conserving Device. Crit Care Med. 2005 Mar;33(3):585-90. doi: 10.1097/01.ccm.0000156294.92415.e2."},{"pmid":"15640636","type":"BACKGROUND","citation":"Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med. 2004 Nov;32(11):2241-6. doi: 10.1097/01.ccm.0000145951.76082.77."},{"pmid":"22824929","type":"DERIVED","citation":"Villa F, Iacca C, Molinari AF, Giussani C, Aletti G, Pesenti A, Citerio G. Inhalation versus endovenous sedation in subarachnoid hemorrhage patients: effects on regional cerebral blood flow. Crit Care Med. 2012 Oct;40(10):2797-804. doi: 10.1097/CCM.0b013e31825b8bc6."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000013345","term":"Subarachnoid Hemorrhage"},{"id":"D000006470","term":"Hemorrhage"}],"ancestors":[{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020300","term":"Intracranial Hemorrhages"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M9246","name":"Hemorrhage","asFound":"Hemorrhage","relevance":"HIGH"},{"id":"M15825","name":"Subarachnoid Hemorrhage","asFound":"Subarachnoid Hemorrhage","relevance":"HIGH"},{"id":"M21803","name":"Intracranial Hemorrhages","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000015742","term":"Propofol"},{"id":"D000007530","term":"Isoflurane"}],"ancestors":[{"id":"D000006993","term":"Hypnotics and Sedatives"},{"id":"D000002492","term":"Central Nervous System Depressants"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000018686","term":"Anesthetics, Intravenous"},{"id":"D000018681","term":"Anesthetics, General"},{"id":"D000000777","term":"Anesthetics"},{"id":"D000018685","term":"Anesthetics, Inhalation"}],"browseLeaves":[{"id":"M17997","name":"Propofol","asFound":"Infection","relevance":"HIGH"},{"id":"M10252","name":"Isoflurane","asFound":"Bypass Surgery","relevance":"HIGH"},{"id":"M3797","name":"Anesthetics","relevance":"LOW"},{"id":"M9733","name":"Hypnotics and Sedatives","relevance":"LOW"},{"id":"M20456","name":"Anesthetics, Intravenous","relevance":"LOW"},{"id":"M20451","name":"Anesthetics, General","relevance":"LOW"},{"id":"M20455","name":"Anesthetics, Inhalation","relevance":"LOW"}],"browseBranches":[{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}